Repetitive stress induces a decrease in sound-evoked activity. by Ghattas Bisharat (20706928)

“…These mice exhibited a minimal change in noise-evoked PPy activity when comparing the first and second week of imaging (2-way ANOVA, F = 1.79, <i>p</i> = 0.11, post hoc baseline w1 50 dB: baseline w2 50 dB <i>p</i> = 1 Bonferroni corrected, nested ANOVA (mouse nested within session) F = 1.76, <i>p</i> = 0.12, mean ± SE). …”

Associations between characteristics of Stories for Change Diabetes participants and meaningful decrease in hemoglobin A1c (HbA1c) from baseline to 3 months (N = 227).... by Abby M. Lohr (11263772)

“…<p>Associations between characteristics of Stories for Change Diabetes participants and meaningful decrease in hemoglobin A1c (HbA1c) from baseline to 3 months (N = 227).…”

Graphical presentation of % decrease for insulin from baseline at different conditions. by Nathan Mubiru (21627195)

Graphical presentation of % decrease for C-peptide from baseline at different conditions. by Nathan Mubiru (21627195)

Changes in baseline T-cell activation markers through week 12 and week 24 according to the linear regression model. a. by Tosi M. Mwakyandile (16408705)

Changes in baseline T-cell exhaustion, monocyte activation and platelet activation markers through week 12 and week 24 according to the linear regression model. a. by Tosi M. Mwakyandile (16408705)

Unadjusted and adjusted odds ratios for associations between Stories for Change Diabetes participant characteristics and meaningful change in hemoglobin A1c (HbA1c) from baseline t... by Abby M. Lohr (11263772)

Histogram of number of drugs with (a) increased and (b) decreased usage within 12 months. by Nguyen Thach (20347852)

Baseline patient characteristics. by Oscar F. C. van den Bosch (22184246)

“…Participants were randomly assigned to receive an infusion of either s-ketamine (0.3 mg kg^-1 h^-1), midazolam (0.05 mg kg^-1 h^-1), or saline in a blinded fashion. …”

<b>Supporting data for manuscript</b> "<b>Voluntary locomotion induces an early and remote hemodynamic decrease in the large cerebral veins</b>" by Kira Shaw (18796168)

“…The locomotion values (traces and metrics) are in arbitrary units with larger integers representing a greater displacement of the spherical treadmill, the hemodynamic (Hbt) values (traces and metrics) are a percentage change from the normalised baseline (prior to stimulus presentation), and the corresponding time series vector is presented in seconds. …”

Changes in baseline CD4 count through week 12 and week 24 according to the linear regression model. by Tosi M. Mwakyandile (16408705)

Most frequently experienced adverse events among study participants by treatment arms from baseline through week 24. by Tosi M. Mwakyandile (16408705)

Cumulative incidence of mortality and loss to follow-up (LTF) among study participants by treatment arms from baseline through week 24. by Tosi M. Mwakyandile (16408705)

Long-term anti-nucleocapsid response by baseline patient characteristics. by Elizabeth S. Munroe (21568166)

Baseline patient characteristics across neutralizing monoclonal antibody trials. by Elizabeth S. Munroe (21568166)

Cumulative incidence of morbidity, loss to follow-up (LTF) and mortality among study participants by treatment arms from baseline through week 24. by Tosi M. Mwakyandile (16408705)

Median changes in CD4 count, platelet activation, immune activation, and exhaustion markers from baseline through week 12 and week 24. by Tosi M. Mwakyandile (16408705)

(A) Auxiliary marking points to ensure complete and accurate seating of the prosthesis. by Long Li (6555)

Antibody and antigen responses by baseline anti-spike neutralizing response assay positivity. by Elizabeth S. Munroe (21568166)

Baseline characteristics. by Si-Jing Chen (15350263)

“…In addition, the CBT-I group reported a greater decrease in depressive (adjusted difference −1.0 [−1.6 to −0.5]; Cohen’s <i>d</i> = 0.53; <i>p</i> < 0.001) and insomnia symptoms (−2.0 [−2.7 to −1.3], <i>d</i> = 0.78; <i>p</i> < 0.001) than the controls at post-intervention and throughout 6-month follow-up. …”